Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
Cell Rep ; 37(12): 110133, 2021 12 21.
Article in English | MEDLINE | ID: mdl-34936875

ABSTRACT

Intracellular calcium signaling underlies the astroglial control of synaptic transmission and plasticity. Mitochondria-endoplasmic reticulum contacts (MERCs) are key determinants of calcium dynamics, but their functional impact on astroglial regulation of brain information processing is unexplored. We found that the activation of astrocyte mitochondrial-associated type-1 cannabinoid (mtCB1) receptors determines MERC-dependent intracellular calcium signaling and synaptic integration. The stimulation of mtCB1 receptors promotes calcium transfer from the endoplasmic reticulum to mitochondria through a specific molecular cascade, involving the mitochondrial calcium uniporter (MCU). Physiologically, mtCB1-dependent mitochondrial calcium uptake determines the dynamics of cytosolic calcium events in astrocytes upon endocannabinoid mobilization. Accordingly, electrophysiological recordings in hippocampal slices showed that conditional genetic exclusion of mtCB1 receptors or dominant-negative MCU expression in astrocytes blocks lateral synaptic potentiation, through which astrocytes integrate the activity of distant synapses. Altogether, these data reveal an endocannabinoid link between astroglial MERCs and the regulation of brain network functions.


Subject(s)
Astrocytes/metabolism , Calcium/metabolism , Cannabinoids/metabolism , Endoplasmic Reticulum/metabolism , Mitochondria/metabolism , Receptors, Cannabinoid/physiology , Synapses/physiology , Animals , Astrocytes/cytology , Calcium Channels/physiology , Calcium Signaling , Cells, Cultured , Hippocampus/metabolism , Homeostasis , Mice , Mice, Inbred C57BL , Neuronal Plasticity , Synaptic Transmission
3.
Neuron ; 109(9): 1513-1526.e11, 2021 05 05.
Article in English | MEDLINE | ID: mdl-33770505

ABSTRACT

Recent advances in neuroscience have positioned brain circuits as key units in controlling behavior, implying that their positive or negative modulation necessarily leads to specific behavioral outcomes. However, emerging evidence suggests that the activation or inhibition of specific brain circuits can actually produce multimodal behavioral outcomes. This study shows that activation of a receptor at different subcellular locations in the same neuronal circuit can determine distinct behaviors. Pharmacological activation of type 1 cannabinoid (CB1) receptors in the striatonigral circuit elicits both antinociception and catalepsy in mice. The decrease in nociception depends on the activation of plasma membrane-residing CB1 receptors (pmCB1), leading to the inhibition of cytosolic PKA activity and substance P release. By contrast, mitochondrial-associated CB1 receptors (mtCB1) located at the same terminals mediate cannabinoid-induced catalepsy through the decrease in intra-mitochondrial PKA-dependent cellular respiration and synaptic transmission. Thus, subcellular-specific CB1 receptor signaling within striatonigral circuits determines multimodal control of behavior.


Subject(s)
Brain/metabolism , Receptor, Cannabinoid, CB1/metabolism , Signal Transduction/physiology , Synaptic Transmission/physiology , Animals , Brain/drug effects , Cannabinoid Receptor Agonists/pharmacology , Cannabinoid Receptor Antagonists/pharmacology , Catalepsy/chemically induced , Cell Membrane/metabolism , HEK293 Cells , HeLa Cells , Humans , Male , Mice , Mice, Inbred C57BL , Mitochondria/metabolism , Nociception/drug effects , Nociception/physiology , Signal Transduction/drug effects , Synaptic Transmission/drug effects
4.
Neuron ; 98(5): 935-944.e5, 2018 06 06.
Article in English | MEDLINE | ID: mdl-29779943

ABSTRACT

Bidirectional communication between neurons and astrocytes shapes synaptic plasticity and behavior. D-serine is a necessary co-agonist of synaptic N-methyl-D-aspartate receptors (NMDARs), but the physiological factors regulating its impact on memory processes are scantly known. We show that astroglial CB1 receptors are key determinants of object recognition memory by determining the availability of D-serine at hippocampal synapses. Mutant mice lacking CB1 receptors from astroglial cells (GFAP-CB1-KO) displayed impaired object recognition memory and decreased in vivo and in vitro long-term potentiation (LTP) at CA3-CA1 hippocampal synapses. Activation of CB1 receptors increased intracellular astroglial Ca2+ levels and extracellular levels of D-serine in hippocampal slices. Accordingly, GFAP-CB1-KO displayed lower occupancy of the co-agonist binding site of synaptic hippocampal NMDARs. Finally, elevation of D-serine levels fully rescued LTP and memory impairments of GFAP-CB1-KO mice. These data reveal a novel mechanism of in vivo astroglial control of memory and synaptic plasticity via the D-serine-dependent control of NMDARs.


Subject(s)
Astrocytes/metabolism , Neurons/metabolism , Receptor, Cannabinoid, CB1/genetics , Receptors, N-Methyl-D-Aspartate/metabolism , Recognition, Psychology/physiology , Serine/metabolism , Synapses/metabolism , Animals , CA1 Region, Hippocampal/metabolism , CA3 Region, Hippocampal/metabolism , Hippocampus , In Vitro Techniques , Long-Term Potentiation , Memory , Mice , Mice, Knockout , Neuronal Plasticity , Receptor, Cannabinoid, CB1/metabolism
5.
Glia ; 66(7): 1417-1431, 2018 07.
Article in English | MEDLINE | ID: mdl-29480581

ABSTRACT

Astroglial type-1 cannabinoid (CB1 ) receptors are involved in synaptic transmission, plasticity and behavior by interfering with the so-called tripartite synapse formed by pre- and post-synaptic neuronal elements and surrounding astrocyte processes. However, little is known concerning the subcellular distribution of astroglial CB1 receptors. In particular, brain CB1 receptors are mostly localized at cells' plasmalemma, but recent evidence indicates their functional presence in mitochondrial membranes. Whether CB1 receptors are present in astroglial mitochondria has remained unknown. To investigate this issue, we included conditional knock-out mice lacking astroglial CB1 receptor expression specifically in glial fibrillary acidic protein (GFAP)-containing astrocytes (GFAP-CB1 -KO mice) and also generated genetic rescue mice to re-express CB1 receptors exclusively in astrocytes (GFAP-CB1 -RS). To better identify astroglial structures by immunoelectron microscopy, global CB1 knock-out (CB1 -KO) mice and wild-type (CB1 -WT) littermates were intra-hippocampally injected with an adeno-associated virus expressing humanized renilla green fluorescent protein (hrGFP) under the control of human GFAP promoter to generate GFAPhrGFP-CB1 -KO and -WT mice, respectively. Furthermore, double immunogold (for CB1 ) and immunoperoxidase (for GFAP or hrGFP) revealed that CB1 receptors are present in astroglial mitochondria from different hippocampal regions of CB1 -WT, GFAP-CB1 -RS and GFAPhrGFP-CB1 -WT mice. Only non-specific gold particles were detected in mouse hippocampi lacking CB1 receptors. Altogether, we demonstrated the existence of a precise molecular architecture of the CB1 receptor in astrocytes that will have to be taken into account in evaluating the functional activity of cannabinergic signaling at the tripartite synapse.


Subject(s)
Astrocytes/metabolism , Astrocytes/ultrastructure , Hippocampus/metabolism , Hippocampus/ultrastructure , Receptor, Cannabinoid, CB1/metabolism , Animals , Glial Fibrillary Acidic Protein/genetics , Glial Fibrillary Acidic Protein/metabolism , Immunoenzyme Techniques , Mice, Knockout , Microscopy, Immunoelectron , Mitochondria/metabolism , Mitochondria/ultrastructure , Receptor, Cannabinoid, CB1/genetics
6.
Nat Neurosci ; 20(11): 1540-1548, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28945222

ABSTRACT

The amygdala plays key roles in fear and anxiety. Studies of the amygdala have largely focused on neuronal function and connectivity. Astrocytes functionally interact with neurons, but their role in the amygdala remains largely unknown. We show that astrocytes in the medial subdivision of the central amygdala (CeM) determine the synaptic and behavioral outputs of amygdala circuits. To investigate the role of astrocytes in amygdala-related behavior and identify the underlying synaptic mechanisms, we used exogenous or endogenous signaling to selectively activate CeM astrocytes. Astrocytes depressed excitatory synapses from basolateral amygdala via A1 adenosine receptor activation and enhanced inhibitory synapses from the lateral subdivision of the central amygdala via A2A receptor activation. Furthermore, astrocytic activation decreased the firing rate of CeM neurons and reduced fear expression in a fear-conditioning paradigm. Therefore, we conclude that astrocyte activity determines fear responses by selectively regulating specific synapses, which indicates that animal behavior results from the coordinated activity of neurons and astrocytes.


Subject(s)
Amygdala/physiology , Astrocytes/physiology , Fear/physiology , Maze Learning/physiology , Nerve Net/physiology , Synapses/physiology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Adenosine A2 Receptor Antagonists/pharmacology , Amygdala/cytology , Amygdala/drug effects , Animals , Astrocytes/drug effects , Fear/drug effects , Fear/psychology , Male , Maze Learning/drug effects , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Net/cytology , Nerve Net/drug effects , Organ Culture Techniques , Receptor, Adenosine A2A/physiology , Synapses/drug effects
7.
Nature ; 539(7630): 555-559, 2016 11 24.
Article in English | MEDLINE | ID: mdl-27828947

ABSTRACT

Cellular activity in the brain depends on the high energetic support provided by mitochondria, the cell organelles which use energy sources to generate ATP. Acute cannabinoid intoxication induces amnesia in humans and animals, and the activation of type-1 cannabinoid receptors present at brain mitochondria membranes (mtCB1) can directly alter mitochondrial energetic activity. Although the pathological impact of chronic mitochondrial dysfunctions in the brain is well established, the involvement of acute modulation of mitochondrial activity in high brain functions, including learning and memory, is unknown. Here, we show that acute cannabinoid-induced memory impairment in mice requires activation of hippocampal mtCB1 receptors. Genetic exclusion of CB1 receptors from hippocampal mitochondria prevents cannabinoid-induced reduction of mitochondrial mobility, synaptic transmission and memory formation. mtCB1 receptors signal through intra-mitochondrial Gαi protein activation and consequent inhibition of soluble-adenylyl cyclase (sAC). The resulting inhibition of protein kinase A (PKA)-dependent phosphorylation of specific subunits of the mitochondrial electron transport system eventually leads to decreased cellular respiration. Hippocampal inhibition of sAC activity or manipulation of intra-mitochondrial PKA signalling or phosphorylation of the Complex I subunit NDUFS2 inhibit bioenergetic and amnesic effects of cannabinoids. Thus, the G protein-coupled mtCB1 receptors regulate memory processes via modulation of mitochondrial energy metabolism. By directly linking mitochondrial activity to memory formation, these data reveal that bioenergetic processes are primary acute regulators of cognitive functions.


Subject(s)
Cannabinoids/adverse effects , Memory Disorders/chemically induced , Memory/drug effects , Memory/physiology , Mitochondria/drug effects , Mitochondria/metabolism , Adenylyl Cyclases/metabolism , Animals , Cannabinoids/metabolism , Cell Respiration/drug effects , Cyclic AMP-Dependent Protein Kinases/metabolism , Electron Transport/drug effects , Energy Metabolism/drug effects , Female , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Male , Memory Disorders/enzymology , Memory Disorders/metabolism , Memory Disorders/pathology , Mice , Mitochondrial Membranes/drug effects , Mitochondrial Membranes/enzymology , Mitochondrial Membranes/metabolism , NADH Dehydrogenase/metabolism , Oxidative Phosphorylation/drug effects , Receptor, Cannabinoid, CB1/deficiency , Receptor, Cannabinoid, CB1/genetics , Receptor, Cannabinoid, CB1/metabolism , Signal Transduction/drug effects , Synaptic Transmission/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...